MEREO BIOPHARMA GROUP PLC (MREO) Operating margin 2023–2025
MEREO BIOPHARMA GROUP PLC (MREO) operating margin by fiscal year — reported operating income divided by reported revenue.
-8021.4%FY2025 · since FY2023: -284.2% → -8021.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8021.4% | — |
| FY2023 | -284.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More MREO financial trends
MREO RevenueMREO Net incomeMREO Net marginMREO Gross profitMREO Gross marginMREO Operating incomeMREO Operating cash flowMREO Free cash flowMREO Capital expendituresMREO Return on equityMREO Stock buybacksMREO Dividends paidMREO Total assetsMREO Total liabilitiesMREO Shareholders’ equityMREO overview →